Veterinary PoC Diagnostics Market Expected to Reach $1.72 Billion by 2031

Overview of the Veterinary PoC Diagnostics Market

The Veterinary Point-of-Care (PoC) Diagnostics market presents significant growth prospects, projected to increase from approximately USD 1.19 billion in 2026 to USD 1.72 billion by 2031. This represents a compound annual growth rate (CAGR) of 7.7%. The rising demand for quick and accurate disease diagnostics in veterinary care plays a crucial role in this growth.

Key Drivers of Growth

1. Growing Need for Rapid Testing: The increasing preference for rapid diagnosis in veterinary practices is driving the growth of the PoC diagnostics market. The ability to provide immediate results allows clinicians to make timely treatment decisions, benefiting both companion and livestock animals.

2. Technological Advancements: Innovations in diagnostic technologies have led to the development of novel platforms such as portable molecular diagnostics, handheld analyzers, and microfluidics-based systems. These technologies offer enhanced sensitivity and specificity, allowing for more precise diagnostics at the point of care.

3. Rise in Pet Ownership and Expanding Health Awareness: The growing trend of pet ownership has contributed significantly to the increased expenditure on veterinary healthcare. Owners are now more interested in preventive care and routine screenings, which further drives the demand for PoC diagnostics.

Market Segmentation Insights

Product Segmentation:
The consumables segment held a dominant share of approximately 88.0% in 2025. This category includes essential items such as test kits, cartridges, and reagents. Due to the need for continuous testing, this segment experiences repeat demand, leading to higher utilization rates compared to one-time instrument purchases.

Technological Trends:
In terms of technology, the immunodiagnostics segment is expected to continue its dominance, accounting for 84.7% of the market in 2025. However, the molecular diagnostics segment is forecasted to record the highest CAGR in upcoming years, driven by its ability to detect pathogens early, even in low concentrations. Innovations in PCR and isothermal amplification technologies are making these tests more accessible in veterinary settings.

Regional Insights:
From a geographical perspective, Asia Pacific is estimated to exhibit the highest CAGR of 9.0% during the forecast period. North America held the largest market share in 2025, attributed to its robust veterinary healthcare infrastructure and the increasing adoption of rapid diagnostics. The region’s awareness regarding early disease detection and quick clinical decisions supports extensive PoC diagnostic use.

Key Companies in the Market

Several significant players are shaping the Veterinary PoC diagnostics landscape, including:

- IDEXX Laboratories, Inc. (USA)
- Zoetis Services LLC (USA)
- Thermo Fisher Scientific Inc. (USA)
- bioMérieux (France)
- Neogen Corporation (USA)

These companies are actively pursuing innovative solutions with features like multiplex testing that enhance diagnostic accuracy and reduce turnaround times. The trend toward user-friendly, portable systems with enhanced connectivity is also notable, ensuring that practitioners can have real-time data at their disposal for efficient monitoring and decision-making.

Conclusion

The Veterinary PoC diagnostics market is on an upward trajectory, significantly influenced by technological advancements, innovations in testing solutions, and an increasing focus on preventive care. The continued expansion of this market underscores the vital need for rapid and accurate diagnostics that can facilitate better health outcomes for animals. As we look ahead to 2031, stakeholders in this market must stay attuned to emerging technologies and evolving consumer expectations to thrive in an increasingly competitive landscape.